SECTION27 is a public interest law centre that seeks to influence, develop and use the law to protect, promote and advance human rights. Our name is drawn from the section in the South African Constitution which enshrines everyone's right to health care, food, water and social security.
The Global Health Workforce Alliance announces the launch of a microsite, developed in partnership with the Guardian, to highlight and raise awarenes of the global health workforce crisis ahead of the Second Global Forum on Human Resources for Health, in Bangkok, 25 – 29 January 2011.
SECTION27 and TAC applauds the successful ARV medicine tender – but call for continued actions to drive prices of essential medicines down further.
SECTION27 and TAC applaud the Minister of Health and his team at the Department of Health (DoH) for their part in conceptualising, implementing and concluding a successful antiretroviral (ARV) medicine tender. Announced yesterday, the 2010 tender – for the period 1 January 2011 to 31 December 2012 – will see the state procuring ARV medicines at or about the best prices available globally.
Médecins Sans Frontières/Doctors without Borders (MSF) and the University of Johannesburg’s (UJ’s) Faculty of Health Sciences have partnered to raise awareness and encourage discussion on public health-related issues through a series of high-level debates. In the second of this series, the panel addressed critical issues from challenges hampering the ability of the public health system to provide treatment, care and support, to legal frameworks and opportunities such as innovative financing mechanisms for global health.
SECTION27 and the Treatment Action Campaign (TAC) welcome the results of the Pre-exposure Prophylaxis Initiative (iPrEX) trial. Published yesterday in the New England Journal of Medicine (NEJM), the study is the first to establish that pre-exposure prophylaxis (PrEP) – taking antiretroviral (ARV) medicines before sex – reduces the risk of HIV infection. It follows closely on the heels of the CAPRISA 004 trial, which demonstrated that the use of tenofovir 1% gel reduced the risk of HIV infection amongst women at increased risk.
The iPrEx trial enrolled 2499 men who have sex with men (MSM) at 11 sites across the world (including Cape Town). Half of the trial participants were randomly assigned to take a daily dose of two ARV medicines – tenofovir disproxil fumarate (TDF) and emtricitabine (FTC) – combined into a single pill. The other half, also randomly assigned, received a daily placebo. All received a comprehensive package of HIV prevention services, including regular HIV testing, risk-reduction counselling, condoms, and the treatment of symptomatic sexually transmitted infections.
Joint Action and Learning Initiative on National and Global Responsibilities for Health (JALI) is the beginning of a global coalition of civil society organisations and academia collaborating to challenge inequality in access to health care around the world and to develop strategies to promote and fulfill the human right to health. JALI’s ultimate goal is to develop and see implemented a Framework Convention on Global Health that will serve to guide all countries on their global responsibilities – both individually and collectively – to ensuring access to health care.